Medical Affairs
Medical resources for healthcare providers
The resources on this page are offered to US healthcare providers who are engaging with Medical Affairs at ADMA Biologics.
ADMA is committed to improving patient care by providing educational information to healthcare professionals and patients. ADMA is devoted to supporting research and provides grants and sponsorships for academic and other medical centers, medical and professional societies, and patient organizations that are aligned with ADMA’s mission.
Leading the way with innovative immune globulin products
ADMA Biologics is an end-to-end commercial biopharmaceutical company leading a new age of manufacturing, marketing, and commercializing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for certain infections. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.
With three FDA-licensed approved products, including ASCENIV™ (Immune Globulin Intravenous, Human – slra), BIVIGAM® (Immune Globulin Intravenous, Human), and NABI-HB® (Hepatitis B Immune Globulin, Human), ADMA’s mission is to continue to successfully develop and commercialize plasma-derived, human immune globulins targeted to specific patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations.
Medical Information Request (MIR)
Healthcare professionals may request specific product information on ADMA’s commercial products (ASCENIV™, BIVIGAM® and NABI-HB®), as well as questions about therapeutic areas and disease states.
Please provide the information below.
Investigator-Initiated Research (IIR) Proposal
ADMA is committed to providing innovative, high-quality specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection. ADMA Biologics strives to advance science through supporting cutting-edge research conducted by qualified external parties.
Request Process and Requirements
All investigators requesting funding for an investigator-initiated research need to complete the form on this page (Rationale for the study, Study Objectives, Methods, Brief outline of Protocol, Preliminary Budget). A more detailed protocol will be requested if the study proposal is accepted.
Evaluation of Requests
ADMA Biologics evaluates all IIR proposals based on established criteria, including ADMA Biologics business procedures, and compliance with any applicable US FDA or federal healthcare program requirements. ADMA Biologics adheres to the strict policy that IIRs are not opportunities to promote an approved or unapproved product to investigators who may also be prescribers or otherwise influence the use of ADMA products.
Please provide the information below.
Medical Education Grant Proposal
ADMA is committed to supporting independent, high-quality educational programs for HCPs that contribute to the improvement of patient care in the therapeutic areas in which ADMA has research and commercial interests.
Request Process and Requirements
Programs supported by Medical Educational Grants must be exclusively controlled by the recipient. Grants are provided solely on the basis of scientific, medical and public health criteria, and may not be used as an inducement or reward for the purchase, use or recommendation of, or to promote, an ADMA product.
The proposal should be submitted at least 60 days prior to the Educational Program planned date. The requestor(s) should submit specific information and details as it relates to the request (organization, contact person, title of project, description of project/ timeline, budget).
Evaluation of Requests
All requests will be evaluated by the Educational Grant Review Committee. Independent reviews of requests will be conducted to make determinations whether such requests comply with ADMA’s procedures, any applicable laws and whether they should be approved or declined.
Please provide the information below.